Invited Speakers 2018-02-05T18:10:29+00:00
AUSTRALASIAN DIABETES CONGRESS 2018
Stephanie Amiel

Prof Stephanie Amiel

ADS Plenary Speaker

Prof Amiel is a senior clinician and experimental medicine researcher at King’s College Hospital and King’s College London in the UK. She trained at Guy’s Hospital in London and studied under both Prof Harry Keen, leader of the UK team that developed insulin pump therapy, and Profs Robert Sherwin and Bill Tamborlane, inventors of insulin pump therapy in the US.  She has continued to focus, clinically and academically, on reducing risk of hypoglycaemia in diabetes therapies.

With colleagues across the UK, she developed the UK’s DAFNE programme, and locally, the King’s islet transplant programme – the King’s Diabetes Service currently supports over 700 pump and 150 sensor users. Prof Amiel’s current research focuses on the role of the brain in the control of metabolism (hypoglycaemia and insulin resistance); the impact of ethnicity on metabolism and the further understanding of hypoglycaemia in diabetes. She is currently running a JDRF-funded randomised controlled trial of a novel intervention to prevent hypoglycaemia based on her research. Prof Amiel has published widely. She chaired the 2015 revision of the UK’s NICE guidelines for the management of type 1 diabetes in adults and continues to work with charities and other bodies to improve management of type 1 diabetes.

Linda Beeney

Dr Linda Beeney, PhD

ADEA Plenary Speaker

Dr Linda Beeney, PhD (Medicine, USyd) is Principal Investigator of the ReMinD Program (Researching Media in Diabetes) and holds a teaching & research position as Honorary Associate with Sydney Medical School, The University of Sydney. She completed her undergraduate degree in Psychology and her PhD in Medicine at The University of Sydney as an NHMRC Scholar, was awarded an NHMRC Travelling Fellowship and completed a Post-doctoral Fellowship at Harvard Medical School.

Dr Beeney’s current research is focused on experimental studies of diabetes language, analysis of media messages about diabetes and framing of complications risk communication, thanks to funding support from the ADEA Research Foundation, Medical Psychology Services, ACU and The University of the Sunshine Coast.

Dr Beeney has published numerous academic papers from her research collaborations in the areas of diabetes psychology, psycho-oncology and emergency medicine.

Dr Beeney has a thriving private practice as a Diabetes Psychologist and is the Director of Medical Psychology Services, a consultancy specializing in medical illness research and industry collaboration.

Prof Eva Feldman

Prof Eva Feldman

ADS Plenary Speaker

Professor Eva Feldman is a clinician-scientist whose career focuses on understanding the neurological complications of obesity and diabetes. With 25 years of continuous funding from NIH, she is Principal Investigator on 3 multi-institutional grants to complete comprehensive transcriptomic, proteomic, and metabolomic phenotyping of obese and diabetic children and adults, with the goal to understand the pathogenesis of neurological complications, particularly diabetic neuropathy.

She also oversees 5 NIH grants supporting basic scientific research employing cellular and murine models of metabolic injury. Her findings are published in 375 manuscripts, 70 book chapters, and she has authored 4 books. Professor Feldman served as President of the American Neurological Association and is a member of the National Academy of Medicine. She has received lifetime achievement awards from the ADA, JDRF and the Endocrine Society. In 2016, she was named the National Physician of the Year for Clinical Excellence among the Best Doctors in America.

Dr Jeremy Grimshaw

Dr Jeremy Grimshaw

ADS Plenary Speaker

Dr Jeremy Grimshaw MBChB, PhD is an internationally leading implementation researcher whose research focuses on the evaluation of interventions to disseminate and implement evidence-based practice.  He is a Senior Scientist, Clinical Epidemiology Program, Ottawa Hospital Research Institute, a Full Professor in the Department of Medicine, University of Ottawa and a Tier 1 Canada Research Chair in Health Knowledge Transfer and Uptake.

His research focusses on systematic reviews of interventions to improve healthcare delivery and healthcare systems, large scale field evaluations (usually cluster randomised trials) of dissemination and implementation interventions and the use of behavioural approaches to optimise dissemination and implementation interventions. He has undertaken a landmark series of systematic reviews of diabetes quality improvement interventions as well as primary implementation research in diabetes. He has over 540 publications and a h-index of 88.

Prof Rohit Kulkarni

Prof Rohit Kulkarni

ADS Plenary Speaker

Rohit N. Kulkarni, M.D., Ph.D., is Professor of Medicine at Harvard Medical School, Senior Investigator and Co-Head of the Section on Islet Cell and Regenerative Biology at the Joslin Diabetes Center, Principal Faculty at the Harvard Stem Cell Institute in Boston and Associate Member of the Broad Institute in Cambridge, USA and currently holds the inaugural Margaret A. Congleton Endowed Chair.

Dr. Kulkarni received his medical degree from Bangalore Medical College and continued at St. John’s Medical College where he started research under the supervision of Prof. PS Shetty MD. Subsequently, he worked at Hammersmith Hospital as an Honorary Clinical Registrar while also working on his PhD (Biochemistry) from the Royal Postgraduate Medical School (University of London) under the mentorship of Sir Steve Bloom FRS. Dr. Kulkarni then undertook a Post-doctoral Fellowship in Cell Physiology in the lab of C. Ronald Kahn MD at the Joslin Diabetes Center. In 1999 Dr. Kulkarni was recruited to the Faculty at Joslin Diabetes Center and Department of Medicine (Harvard Medical School, Boston). Dr. Kulkarni is a recipient of the Endocrine Society’s Ernst Oppenheimer Award for Outstanding Research and is an elected member of the American Society for Clinical Investigation and the Association of American Physicians. Dr. Kulkarni is a recipient of the James H. Horner Distinguished Visiting Professorship, the Endocrine Society’s Visiting Professorship in Endogenous Pancreas Preservation, is a Takeda Visiting Scholar, and delivered the Merck Frosst Distinguished Lectureship, the Harlan G. Wood Annual Memorial Lecture, the Prof. M.M.S. Ahuja Oration and the Dr. H.J. Mehta Oration.

His lab is interested in understanding the mechanisms that underlie pancreatic islet cell regeneration with a focus on growth factor signaling, induced pluripotent stem cells and inter-organ crosstalk.

Lisa Nissen

Dr Lisa Nissen

ADEA Plenary Speaker

Dr Lisa Nissen is Professor and Head of the School of Clinical Sciences at Queensland University of Technology. She is an experienced pharmacy practitioner, researcher and educator having worked in hospital and community pharmacy in metropolitan and rural areas Australia. Her focus is on improving the Quality Use of Medicines in the wider community, across the health care continuum, with a focus on health service development and factors that influence the prescribing of medicines.

Lisa is a strong believer in the benefits multidisciplinary health care teams can bring to patient care and takes this passion into the classroom with a commitment to the development and implementation of innovative interprofessional education for health students. She has received National Awards for Teaching Excellence in 2008 and 2013 and been been acknowledged for her contributions to the pharmacy profession, being the Pharmaceutical Society of Australia Young Pharmacist of the Year in 2002 and Pharmacist of the Year in 2008.

Peter Tontonoz

Prof Peter Tontonoz

ADS Plenary Speaker

Peter Tontonoz is the Frances and Albert Piansky Professor of Pathology and Laboratory Medicine and David Geffen School of Medicine Dean’s Scholar at the University of California, Los Angeles.  Dr. Tontonoz received his B.A. from Wesleyan University and his M.D. and Ph.D. from Harvard Medical School.  The focus of his laboratory is the control of gene expression by lipids and the role of nuclear receptors in lipid metabolism.  Dr. Tontonoz’s work has helped to reveal fundamental mechanisms by which animals maintain cellular and whole-body lipid homeostasis.

Dr. Tontonoz is a recipient of the Richard Weitzman and Gerald D. Aurbach Awards from the Endocrine Society, and the Jeffrey Hoeg Award from the American Heart Association.  He has been elected to American Society of Clinical investigation and the Association of American Physicians and is a past President of the American Society for Clinical Investigation.  Dr. Tontonoz serves on a number of editorial boards and he is a Reviewing Editor for eLife and the Editor in Chief of Molecular and Cellular Biology.